Raman spectroscopy differentiates between sensitive and resistant multiple myeloma cell lines
- 1 December 2017
- journal article
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 187, 15-22
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- New orally active proteasome inhibitors in multiple myelomaLeukemia Research, 2014
- Monoclonal antibodies: potential new therapeutic treatment against multiple myelomaEuropean Journal of Haematology, 2013
- Management of treatment-related adverse events in patients with multiple myelomaCancer Treatment Reviews, 2010
- Dexamethasone-induced apoptosis and up-regulation of Bim is dependent on glycogen synthase kinase-3Leukemia Research, 2009
- Treatment of Relapsed/Refractory Multiple MyelomaSeminars in Hematology, 2009
- Proteasome Inhibition in the Treatment of CancerCell Cycle, 2004
- A Phase 2 Study of Bortezomib in Relapsed, Refractory MyelomaNew England Journal of Medicine, 2003
- Dexamethasone-induced apoptosis of thymocytes: role of glucocorticoid receptor–associated Src kinase and caspase-8 activationBlood, 2003
- Polyamine-depletion induces p27Kip1 and enhances dexamethasone-induced G1 arrest and apoptosis in human T lymphoblastic leukemia cellsLeukemia Research, 2000
- Glucocorticoid Receptor-Mediated Cell Cycle Arrest Is Achieved through Distinct Cell-Specific Transcriptional Regulatory MechanismsMolecular and Cellular Biology, 1997